“I truly respect an organization like IRMA that does not shy away from talking about sex and pushing for more research in the rectal microbicide field. This is really important work.”
Amber is the Senior Research Associate at Fenway Health. Outside of work, she loves cooking and baking new and exciting recipes.
Amber became involved in IRMA through her current position and was intrigued by IRMA’s ability to talk about sex and push for more research into the rectal microbicide field. She also believes that rectal microbicides are important because “receptive anal intercourse carries the highest risk of sexual HIV transmission. Providing individuals with other methods of protection against HIV and other STIs is vital for community safety.”
She hopes that in time, the stigma associated with receptive anal intercourse will diminish, and men and women will feel more comfortable this very common behavior with health care providers.
Currently, Amber is working on a vaginal ring study called MTN-013/IPM 026. She is very excited about her studies, and is eager to see her research and work evolve.
With the upcoming MTN-017 trial, Amber will be involved in site activation activities, and will be conducting study visits. MTN-017 is the very first Phase II rectal microbicide expanded safety and acceptability study in the field and will recruit gay men, other men who have sex with men, and transgender women who are HIV negative. U.S. sites will launch later in 2012, and international sites are expected to begin enrolling in early 2013. The study will be investigating a reduced-glycerin formulation of tenofovir gel applied rectally compared with oral Truvada.
Amber’s mother has been her greatest influence. Her mother has demonstrated leadership, strength, and compassion, and encourages Amber to pursue all her passions and goals fearlessly.
Thank you, Amber, for all that you do!
*Join IRMA’s robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at email@example.com. Joining our listserv automatically makes you a member of IRMA – a network of more than 1,100 advocates, scientists, policy makers and funders from all over the world.
*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.
*Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article’s content.